Lv3
300 积分 2023-06-02 加入
A simple method for combining binomial counts or proportions with hazard ratios for evidence synthesis of time‐to‐event data
11天前
已完结
Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability
16天前
已完结
Safety and Clinical Efficacy of Recombinant Human Interferon β1b for Treatment of Relapsing-Remitting Multiple Sclerosis
1个月前
已关闭
A double-blind, placebo-controlled, randomized trial of cladribine in relapsing-remitting multiple sclerosis
1个月前
已关闭
Long-Term Efficacy and Safety of Ocrelizumab in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS): Week 96 Results of a Phase II, Randomized, Multicenter Trial (S30.006)
1个月前
已关闭
Long-Term Efficacy and Safety of Ocrelizumab in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS): Week 96 Results of a Phase II, Randomized, Multicenter Trial (S30.006)
1个月前
已关闭
The randomized phase III OPTIMUM study. Ponesimod compared with teriflunomide in patients with relapsing-remitting multiple sclerosis
1个月前
已关闭
ePoster Sessions
2个月前
已完结
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
3个月前
已完结
Comparative Efficacy of Relapsing Multiple Sclerosis Therapies: Model-Based Meta-Analyses for Confirmed Disability Accumulation and Annualized Relapse Rate
5个月前
已完结
皖公网安备34019202002308
